- Home
- GTN vs RCKT Comparison
GTN vs RCKT Comparison
Compare GTN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTN | RCKT |
|---|---|---|
| Founded | 1897 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.5M | 394.2M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GTN | RCKT |
|---|---|---|
| Price | $4.55 | $2.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $6.50 | ★ $8.58 |
| AVG Volume (30 Days) | 872.2K | ★ 2.0M |
| Earning Date | 11-06-2026 | 11-05-2026 |
| Dividend Yield | ★ 6.63% | N/A |
| EPS Growth | N/A | ★ 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $3,095,000,000.00 | N/A |
| Revenue This Year | $17.90 | N/A |
| Revenue Next Year | N/A | $915.60 |
| P/E Ratio | ★ N/A | $3.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.55 | $2.42 |
| 52 Week High | $6.44 | $5.45 |
Technical Indicators
Market Signals| Indicator | GTN | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 34.02 |
| Support Level | $4.47 | N/A |
| Resistance Level | $4.70 | $4.02 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 25.77 | 16.16 |
Price Performance
Historical ComparisonAbout GTN Gray Television Inc.
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.